Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing slow and accelerated rehabilitation after shoulder surgery

Official title: Effects of Slow and Accelerated Rehabilitation Protocols After Latissimus Dorsi Transfer in Massive, Irreparable Rotator Cuff Tears

Run by Hacettepe University · NCT05450510 · Data updated 2026-11-12

This study is testing whether a slower or faster rehabilitation program after shoulder surgery helps people with severe rotator cuff tears recover better.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment38 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Kırşehir)
StatusRecruiting
StartedApril 27, 2022
Main results expectedNovember 27, 2025
Study endsDecember 27, 2025
Registry record updatedMarch 6, 2025
Trial IDNCT05450510 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 with massive, irreparable rotator cuff tears who have not benefited from conservative treatments.

Probably not a fit

Patients with diabetes, neurological issues, or other specific contraindications will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effects of two different rehabilitation protocols—slow and accelerated—following latissimus dorsi transfer surgery for patients with massive, irreparable rotator cuff tears. The research will involve patients aged 18-65 who have not responded to conservative treatments for at least six months. Participants will be assessed based on their recovery outcomes, including pain reduction and functional improvement, to determine which rehabilitation approach yields better results. The study will utilize a randomized design to ensure robust comparisons between the two protocols.

Why it matters

Potential benefit: If successful, this study could lead to improved rehabilitation strategies that enhance recovery and reduce pain for patients undergoing shoulder surgery.

How similar studies have gone: While latissimus dorsi transfer is an established treatment, the comparison of rehabilitation protocols is a novel approach that has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* being in the age range of 18-65 years
* being diagnosed with massive, irreparable rotator cuff tears based on magnetic resonance imaging and clinical continuity tests
* symptoms are unresponsive to conservative care including steroid injections and physiotherapy for at least 6 months
* having a good command of the Turkish language
* scoring above 24 in the Mini Mental State Test
* ≥80% compliance in completing the post-ARCR Phase 1 trainings
* volunteering to participate in the study

Exclusion Criteria:

* diabetes mellitus
* neurological problems
* cervical disc herniation
* visual, verbal, and/or cognitive defects (aphasia, unilateral neglect, etc.)
* systemic inflammatory problems
* hypermobility, trauma, and/or inflammation that could be a contraindication for mobilization
* former shoulder fractures on the affected side
* advanced glenohumeral arthritis (Hamada grade 3),
* deltoid muscle dysfunction,
* irreparable subscapularis tears,
* active infection,
* shoulder stiffness,
* a history of previous shoulder surgery

Where it's running

  • Kırşehir Ahi Evran University
    Kırşehir, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.